Effectiveness and safety of adalimumab to treat outpatient ulcerative colitis: A real-life multicenter, observational study in primary inflammatory bowel disease centers.

A, Tursi; W, Elisei; R, Faggiani; L, Allegretta; ND, Valle; G, Forti; M, Franceschi; A, Ferronato; S, Gallina; T, Larussa; F, Luzza; R, Lorenzetti; G, Mocci; A, Penna; S, Rodino'; L, Sebkova; Medici A, de; G, Pranzo; C, Ricciardelli; G, Grasso; S, Scorza; C, Zampaletta; M, Picchio

doi:10.1097/md.0000000000011897

Public

Effectiveness and safety of adalimumab to treat outpatient ulcerative colitis: A real-life multicenter, observational study in primary inflammatory bowel disease centers.

Shared by NobleBlocks on Aug 1, 2018 • 12:00 AM UTC

Authors:

Tursi A

Elisei W

Faggiani R

Abstract

Adalimumab (ADA) was approved in Italy for the treatment of ulcerative colitis (UC) unresponsive to standard treatments in 2014, but no data from real life are currently available. The aim of the present study was to assess the real-life efficacy and safety of ADA in managing UC outpatients in some ...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!